INTRODUCTION
Many drug-resistant human pathogenic microbes have been observed in the past few decades [1] and it is serious public health problem in a wide range of infectious disease [2, 3] . These resistant pathogenic microbes' strains cause failure in antimicrobial treatment and enhance the mortality risks, and sometimes contribute to complications. To overcome this problem the best way is the development of new bioactive compounds effective against resistant strains is highly needed. In spite of a large number of antibiotics and chemotherapeutics available for medical use, antimicrobial resistance created substantial medical need for new classes of antimicrobial agents. Design and synthesis of newer antimicrobials will always remain an area of immense significance [4] [5] . The novel and potent antimicrobial agents can be obtained by modifying the structure of a well known antimicrobial agent or the second strategy is to combine together two or more different antimicrobial pharmacophores in one molecule.
Coumarin derivatives are an important class of natural, synthetic compounds and pharmacologically active substances displaying a broad range of biological activities including cytotoxicity [6] , antioxidant [7] , antiplasmodial [8] , antimalarial [9] , antirhinovirus [10] , antifungal [11] and antibacterial [12] .
The Mannich reaction is one of the most important carbon-carbon bond forming reactions in organic synthesis because of its atom economy and potential application in the synthesis of biologically active molecules. In this reaction, an amine, two carbonyl compounds, and acid (or base) catalysts are used to produce β-amino carbonyl compounds, which constitute various pharmaceuticals, natural products and versatile synthetic intermediates [13, 14] . Conventional catalyst of the classic Mannich reaction involves inorganic and organic acids like HCl [15] , proline [16] , p-dodecybenzenesulfonic acid [17] . Reaction using these catalysts, however, often suffers drawbacks including long reaction times, harsh reaction condition, and difficult product separation.
Considering the focus on green synthesis in recent years, ionic liquid have attracted attention many of researchers. Ionic liquid have been referred as "designer solvents/ green solvents" because their physical and chemical properties can be adjusted by varying the cation and anion. (22) (23) . Although extensive work has been done in this area, the disadvantage of the above mentioned catalytic systems, are large amount of catalyst required, the necessity of an organic co-solvent, cost, the ionic liquids contain halogen, which in some ways, limits their "greenness". Thus synthesizing halogen free, water soluble, economic, reusable and easy to prepare ionic liquid was the main aim of our research team. Taking in consideration the above mentioned points we have carried out the synthesis of coumarin-dicyclohexyl coupled hybrid derivatives 4(a-o) using [Et 3 NH][HSO 4 ] as an solvent and easily recoverable green catalyst (Scheme 1).
All the synthesized compounds 4(a-o) were screened for in vitro antifungal and antibacterial activity. Minimum inhibitory concentration (MIC) values were determined using the standard agar method as per CLSI guidelines [24] [25] [26] [27] .
RESULTS AND DISCUSSION

Chemistry:
Herein we report the one-pot synthesis of 15 novel 3-((dicyclohexylamino)(substituted In search of an efficient catalyst and the best experimental reaction conditions, the reaction of benzaldehyde (1a), dicyclohexylamine (2) and 4-hydroxy coumarin (3) at room temperature was considered as a standard model reaction to obtain 4a.
Initially, the reaction was carried out in the absence of the catalyst; the product formed in a trace/negligible amount Table 3 . After the completion of the reaction, the reaction mixture was quenched with ice crystals and filtered recrystallized using ethanol. The residual ionic liquid was washed with diethyl ether, dried under vacuum at 60 0 C and reused for subsequent reactions. The recovered ionic liquid could be used for five times without obvious loss of catalytic activity. Table 4 All the synthesized compounds were characterized by 1 H-NMR, 13 C-NMR, mass spectroscopy and IR. 
In-vitro antifungal activity
The newly synthesized compounds 4(a-o) were screened for in vitro antifungal activity against different yeast and filamentous fungal pathogens. All the compounds have shown good to moderate antifungal activity as shown in Table 5 . The compound 4b, 4c, 4d and 4e having electron withdrawing groups exhibited good antifungal activity against these three fungal strains
Aspergillus fumigates (NCIM 902), Aspergillus flavus (NCIM539) and Aspergillus niger (NCIM1196). The compound 4l bearing 4-hydroxy-3-ethoxy was found to be the most active compound among the synthesized series having MIC values 25 µg/ml for C. albicans, 28 µg/ml for C. glabrata, 28 µg/ml for F. oxysporum, 36 µg/ml for Asp. fumigates, 15 µg/ml for Asp.
flavus, 12 µg/ml for Asp. niger, 12 µg/ml for Crypt. Neoformans. 
In-vitro antibacterial activity
The newly synthesized compounds 4(a-o) were screened for in vitro antibacterial activity against different bacterial strains. All the compounds have shown good to moderate antibacterial activity as shown in Table 6 The compound 4b bearing 2,4 difluro was found to be the most active compound among the synthesized series having MIC values 48 µg/ml for E. coli, 50 µg/ml for B. subtilis and 52 µg/ml for S. aureus. 
MATERIALS AND METHODS
General Information
All the reactions were performed in oven-dried glass-wares. All reagents and solvents were used as obtained from the supplier or recrystallized/redistilled unless otherwise noted. The purity of the synthesized compounds was monitored by ascending thin layer chromatography (TLC) on silica gel-G (Merck, Darmstadt, Germany) coated aluminum plates, visualized by iodine vapor and melting points were determined in open capillary tubes. The FTIR spectra were obtained using Jasco FTIR-4000 and peaks were expressed in terms of wave number (cm -1 
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